Nexell Pharmaceuticals Private Limited

Founded in 2022 and headquartered in Gujarat, India.

2022 | Ahmedabad, Gujarat (India) | Active
Last Updated: December 09, 2024

Nexell Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 3 Months

About Nexell Pharmaceuticals

Nexell Pharmaceuticals Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 November 2022 (Two years and three months 14 days old ). Its registered office is in Ahmedabad, Gujarat, India.

The Company is engaged in the Trading Industry.

The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Sumit Khandelwal, Neeru Nagi, and Dhavalkumar Jayswal serve as directors at the Company.

Company Details

  • Location

    Ahmedabad, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U51909GJ2022PTC136478

  • Company No.

    136478

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    01 Nov 2022

  • Date of AGM

    -

  • Date of Balance Sheet

    -

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Trading
Other Industry

Who are the key members and board of directors at Nexell Pharmaceuticals?

Board Members (3)

Name Designation Appointment Date Status
Sumit Khandelwal Country flag representing In Director 01-Nov-2022 Current
Neeru Nagi Country flag representing In Director 01-Nov-2022 Current
Dhavalkumar Jayswal Country flag representing In Director 01-Nov-2022 Current

Financial Performance of Nexell Pharmaceuticals.

Enhance accessibility to Nexell Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Nexell Pharmaceuticals?

Unlock access to Nexell Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Nexell Pharmaceuticals?

Nexell Pharmaceuticals has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nexell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexell Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Nexell Pharmaceuticals

Recent activity within the organization

  • Director Appointment

    Sumit Khandelwal was appointed as a Director was appointed as a Director on 01 Nov 2022 & has been associated with this company since 2 years 3 months .

    01 Nov 2022

  • Director Appointment

    Neeru Vinod Nagi was appointed as a Director was appointed as a Director on 01 Nov 2022 & has been associated with this company since 2 years 3 months .

    01 Nov 2022

  • Director Appointment

    Dhavalkumar Maheshbhai Jayswal was appointed as a Director was appointed as a Director on 01 Nov 2022 & has been associated with this company since 2 years 3 months .

    01 Nov 2022

  • Company Incorporation

    Nexell Pharmaceuticals Private Limited was registered on 01 Nov 2022 with Roc Ahmedabad & aged 2 years 3 months as per MCA records.

    01 Nov 2022

Frequently asked questions

  • Nexell Pharmaceuticals Private Limited was incorporated on 01 Nov 2022.

  • The authorized share capital of Nexell Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Nexell Pharmaceuticals Private Limited.

    • Sumit Khandelwal
    • Neeru Vinod Nagi
    • Dhavalkumar Maheshbhai Jayswal
  • As per Ministry of Corporate Affairs (Mca), the registered address of Nexell Pharmaceuticals Private Limited is 11 Revti Apt. Nr. Saumil School, Maninagar India, Ahmedabad, Gujarat, 380008.

  • The corporate identification number (CIN) of Nexell Pharmaceuticals Private Limited is U51909GJ2022PTC136478 and the company number is 136478 as per Ministry of Corporate Affairs (MCA).